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Using  geographic  information  system  and  molecular 
tools, we characterized a possible outbreak of tuberculo-
sis caused by Mycobacterium tuberculosis Beijing strain in 
17 patients in Cotonou, Benin, during July 2005–October 
2006. Most patients lived or worked in the same area and 
frequented the same local drinking bar. The isolates were 
streptomycin resistant. 
I
n a previous survey aimed at investigating the genetic 
biodiversity  of  Mycobacterium  tuberculosis  in  Coto-
nou, Benin (1), we observed a higher prevalence of strains 
belonging to the Beijing genotype than has been reported 
in other studies in West and Central Africa (2–4). In that 
survey, we applied the results of spoligotyping and typing 
using a 12-loci mycobacterial interspersed repetitive unit–
variable number tandem repeat (MIRU-VNTR) profile to 
identify the genetic lineage of the strains. In the study de-
scribed here, we further investigated the identified Beijing 
strains by characterizing them with the more discriminatory 
set of 24-loci MIRU-VNTR (5). We also mapped the resi-
dences and workplaces of the patients by using geographic 
information system (GIS) technology.
The Study
From July 2005 through October 2006, a survey was 
conducted on 194 isolates of M. tuberculosis obtained from 
194 patients with pulmonary tuberculosis (TB) (1 isolate 
per patient) (1). Patients were recruited from the Nation-
al Hospital for Pneumology and Phtisiology in Cotonou, 
Benin, where most TB patients from the area are treated. 
Cotonou is the largest city in Benin, with a population of 
655,000 in 2002 and an area of 79 km2.
All  patients  gave  informed  consent.  The  study  was 
approved by the National Tuberculosis Program Board of 
Benin.
Among these 194 isolates, 17 belonged to the Beijing 
ST1 family and exhibited the same 12-loci MIRU-VNTR 
pattern (223325163533). One isolate showed additional al-
leles at many loci. The median age of the patients infected 
with the M. tuberculosis strains belonging to the Beijing 
genotype (28 years) was similar to that of patients from the 
general survey (30 years).
Demographic data that included date of birth, age, sex, 
and places of residence and work were collected from each 
patient. Geo-coordinates of each patient’s residence and 
workplace were obtained by using the Global Positioning 
System (GPS) and mapped with the ArcView 3.2 software 
(ESRI, Redlands, CA, USA). We also sought to map a 
place habitually frequented by the patients.
Blood samples for HIV testing were collected from 
each patient. HIV testing was performed by using an ELI-
SA. Seropositive samples were confirmed by a discrimina-
tory HIV1/2 test (Genie II HIV1/HIV2; Bio-Rad, Marnes-
la-Coquette, France).
One sputum sample from each patient was decontami-
nated by using the modified Petroff method and cultured in 
manual Mycobacteria Growth Indicator Tube (MGIT) (6) 
and on Löwenstein-Jensen (LJ) medium. All isolates were 
identified as M. tuberculosis complex by the para-nitroben-
zoic acid method and tested for drug susceptibility against 
rifampin, isoniazid, streptomycin, and ethambutol by us-
ing the proportion method on LJ medium at the following 
respective concentrations: 40 µg/mL, 0.2 µg/mL, 4 µg/mL, 
and 2 µg/mL (7,8).
DNA was extracted by boiling a suspension of 2 drops 
of MGIT-positive cultures in 300 µL of 10 mmol/L Tris-
HCl and 1 mmol/L EDTA, pH 8.0 (1× Tris-EDTA) for 5 
minutes.  MIRU-VNTR  typing  was  performed  at  Geno-
screen (Lille, France) by amplifying each of the 24 inde-
pendent loci, and results were combined into digit allelic 
profiles (5). 
All patients discussed here were born in Benin and had 
lived in the country since birth. How they became infected 
with the M. tuberculosis Beijing strain is unclear. However, 
because some inhabitants of Cotonou are immigrants from 
the Asian continent, this strain could have been brought 
into the country by migrant residents of the community.
In total, 6 (35%) of 17 patients were HIV-1 seroposi-
tive, and the remaining 11 patients (65%) were HIV sero-
negative. In contrast with the results in the initial survey, 
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Maryland, USA.the M. tuberculosis Beijing strain was more likely to be iso-
lated from HIV seropositive patients than from those who 
were HIV seronegative (21 [12%] of 173 (p = 0.024).
Of the 17 M. tuberculosis isolates belonging to the Bei-
jing genotype, drug susceptibility testing results were avail-
able for 16. All isolates from the 16 patients were resistant 
to streptomycin but susceptible to isoniazid, rifampin, and 
ethambutol. Of the remaining 177 isolates from the same 
survey, drug susceptibility testing was available for 127, of 
which only 13 (10.2%) were resistant to streptomycin. The 
M. tuberculosis Beijing strains in this survey were more 
likely to be resistant to streptomycin than were their non-
Beijing  counterparts  (p<0.001).  Other  researchers  have 
suggested that M. tuberculosis Beijing strains may be asso-
ciated with drug resistance (9) and that the rapid spread of 
Beijing strains in some settings suggests an intrinsic viru-
lence of this family (10).
The combination of double alleles in several MIRU-
VNTR loci of 1 isolate suggests a mixed infection (11). 
The other 16 strains showed identical profiles in the 24 
MIRU-VNTR set: loci 154, 424, 577, 580, 802, 960, 1644, 
1955, 2059, 2163b, 2165, 2347, 2401, 2461, 2531, 2687, 
2996, 3007, 3171, 3192, 3690, 4052, 4156, and 4348 with 
the  following  profile:  244233342xx4425163353723.  No 
amplification was achieved for loci 2163b and 2165, de-
spite 2 rounds of PCR for all 16 isolates. This common 
failure to amplify loci 2163b and 2165, which are close in 
the M. tuberculosis chromosome, might be explained by 
a chromosomal deletion in the strain responsible for this 
possible  outbreak.  Having  a  chromosomal  deletion  sup-
ports the hypothesis that all patients were infected by the 
same strain. However, other possible explanations such as 
nucleotide polymorphisms in the sequence complementary 
to PCR primers could not be excluded. Many studies have 
reported pseudo-outbreaks caused by laboratory cross-con-
tamination (12,13). This is not likely in the present study 
because almost all the specimens for primary culture were 
processed on different days over several months.
Mapping  of  patients’  residences  and  workplac-
es  showed  that  many  lived  or  worked  (or  both)  in  the   
Xwlacodji area of Cotonou (Figure). To further investigate 
this spatial cluster and a possible link between patients, 
we mapped a place they habitually frequented and found 
that most patronized the same drinking bar (Figure). Ten 
of the patients either lived or worked near the bar (<300 
m) or regularly visited it. Although no epidemiologic link 
was evident between these patients and the remaining 7 pa-
tients, most of the latter were motorcycle taxi drivers and 
regularly moved from place to place. 
Without GPS we could not have identified the geo-
graphic  cluster  of  these  patients  with  Beijing  strains  in 
Xwlacodji. The residents are poor, and overcrowding cre-
ates conditions favorable for transmission of diseases from 
person to person and rapid spread of the resistant M. tuber-
culosis Beijing strain.
Conclusions 
We cannot completely exclude the unlikely possibility 
that the patients were infected by different strains with the 
same MIRU-VNTR pattern. However, the 17 strains’ iden-
tical 24-loci MIRU-VNTR profile, with a probable deletion 
of the same 2 loci; the identical drug susceptibility pattern 
(monoresistant to streptomycin); and the fact that most pa-
tients resided in the same community as determined by GIS 
strongly suggest that these strains are part of an outbreak.
Generally, molecular tools are used to study TB trans-
mission and to suggest possible outbreaks. Although mo-
lecular tools can help identify an outbreak, they cannot 
localize it. GIS has rarely been used in health systems, 
particularly in resource-poor countries such as Benin (14). 
GIS tools might be dispensable in industrialized countries 
where streets and houses are properly mapped and pin-
pointing specific addresses is generally sufficient to local-
ize an outbreak. In many low-income settings, however, 
streets and houses are not properly numbered and mapped, 
and using GPS is necessary to gain access to accurate geo-
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Figure. Maps showing residences and workplaces of Mycobacterium 
tuberculosis patients in Xwlacodji, Cotonou, Benin, 2005–2006.Mycobacterium tuberculosis Beijing in Benin
coordinates and localize such outbreaks. In the absence of 
genetic methods, differentiating cases from the same route 
of transmission from others is difficult. However, GIS can 
help TB control practitioners identify areas with aggregate 
cases so they can institute appropriate measures to control 
the disease.
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